Budapest, Hungary

Ferenc Bakos



Average Co-Inventor Count = 15.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2008

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovator Ferenc Bakos and His Contributions to Pharmaceutical Chemistry

Introduction

Ferenc Bakos, based in Budapest, Hungary, is a notable inventor in the field of pharmaceutical chemistry. He has contributed significantly through his innovative patent related to the chloromethylation of thiophene, which plays a vital role in the synthesis of pharmaceutically active ingredients.

Latest Patents

Bakos holds a patent for the process of chloromethylation of thiophene, which involves the preparation of 2-chloromethyl-thiophene. This process entails the chloromethylation of thiophene in the presence of compounds containing a keto group. The resulting compounds, designated as formulas (I) and (II), serve as intermediates for various pharmacological products. This innovation potentially paves the way for more efficient synthesis methods in drug development.

Career Highlights

Ferenc Bakos currently works at Sanofi-Aventis, a prominent global healthcare company. His work at this organization has allowed him to focus on developing innovative solutions that enhance the chemical processes involved in drug synthesis. With a patent count of one, his contributions reflect a commitment to advancing pharmaceutical research and development.

Collaborations

Throughout his career, Bakos has had the opportunity to collaborate with esteemed colleagues such as Mátyás Aradi and Zsolt Dombrády. These collaborations have undoubtedly enriched his research endeavors and have likely contributed to the successful development of his patent.

Conclusion

Ferenc Bakos stands out as a creative inventor whose work in the chloromethylation of thiophene has significant implications for pharmaceutical chemistry. His ongoing contributions, particularly through collaborations with talented professionals, continue to shape the landscape of drug development, providing valuable resources for healthcare advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…